Compromised regulation of tissue perfusion and arteriogenesis limit, in an AT1R-independent fashion, recovery of ischemic tissue in Cx40-/- mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 304, Issue 6, 2013, Pages

  Fang, Jennifer S ^a   Angelov, Stoyan N ^a   Simon, Alexander M ^a   Burt, Janis M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

ANG II type 1 receptor; Collateral blood vessels; Connexin 40 deficient; Gap junction; Inflammation; Losartan; Vascular remodeling

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LOSARTAN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE VARIABILITY; BLOOD VESSEL PARAMETERS; CONTROLLED STUDY; FEMALE; GENOTYPE; HINDLIMB; ISCHEMIA; MACROPHAGE MIGRATION; MALE; MICROVASCULAR DENSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE PERFUSION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CONNEXINS; HINDLIMB; ISCHEMIA; LASER-DOPPLER FLOWMETRY; LOSARTAN; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROVESSELS; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, ANGIOTENSIN, TYPE 1; REPERFUSION INJURY;

EID: 84878575448     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00719.2012     Document Type: Article

References (42)

1. Alonso F, Krattinger N, Mazzolai L, Simon A, Waeber G, Meda P, Haefliger JA. An angiotensin II-and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension. Cardiovasc Res 87: 166-176, 2010.
2. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11: 805-815, 1981.
3. Brady AJ. Perindopril versus angiotensin II receptor blockade in hypertension and coronary artery disease: implications of clinical trials. Clin Drug Investig 27: 149-161, 2007.
4. Buschmann I, Pries A, Styp-Rekowska B, Hillmeister P, Loufrani L, Henrion D, Shi Y, Duelsner A, Hoefer I, Gatzke N, Wang H, Lehmann K, Ulm L, Ritter Z, Hauff P, Hlushchuk R, Djonov V, van Veen T, le Noble F. Pulsatile shear and Gja5 modulate arterial identity and remodeling events during flow-driven arteriogenesis. Development 137: 2187-2196, 2010.
5. Cao Y. Monotherapy versus combination therapy of angiogenic and arteriogenic factors for the treatment of ischemic disorders. Curr Mol Med 9: 967-972, 2009.
6. Chadjichristos CE, Scheckenbach KE, van Veen TA, Richani Sarieddine MZ, de WC, Yang Z, Roth I, Bacchetta M, Viswambharan H, Foglia B, Dudez T, Van Kempen MJ, Coenjaerts FE, Miquerol L, Deutsch U, Jongsma HJ, Chanson M, Kwak BR. Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion. Circulation 121: 123-131, 2010.
7. Chalothorn D, Faber JE. Formation and maturation of the native cerebral collateral circulation. J Mol Cell Cardiol 49: 251-259, 2010.
8. Clayton JA, Chalothorn D, Faber JE. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia. Circ Res 103: 1027-1036, 2008.
9. de Wit C, Roos F, Bolz SS, Kirchhoff S, Kruger O, Willecke K, Pohl U. Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res 86: 649-655, 2000.
10. de Wit C, Roos F, Bolz SS, Pohl U. Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics 13: 169-177, 2003.
11. Dupuis F, Atkinson J, Liminana P, Chillon JM. Comparative effects of the angiotensin II receptor blocker, telmisartan, and the angiotensinconverting enzyme inhibitor, ramipril, on cerebrovascular structure in spontaneously hypertensive rats. J Hypertens 23: 1061-1066, 2005.
12. Faber JE, Zhang H, Lassance-Soares RM, Prabhakar P, Najafi AH, Burnett MS, Epstein SE. Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues. Arterioscler Thromb Vasc Biol 31: 1748-1756, 2011.
13. Fabia MJ, Abdilla N, Oltra R, Fernandez C, Redon J. Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens 25: 1327-1336, 2007.
14. Fang JS, Angelov SN, Simon AM, Burt JM. Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery. Am J Physiol Heart Circ Physiol 301: H1872-H1881, 2011.
15. Fang JS, Angelov SN, Simon AM, Burt JM. Cx40 is required for, and cx37 limits, postischemic hindlimb perfusion, survival and recovery. J Vasc Res 49: 2-12, 2012.
16. Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, Winterhager E. Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279: 36931-36942, 2004.
17. Groth W, Blume A, Gohlke P, Unger T, Culman J. Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens 21: 2175-2182, 2003.
18. Harari OA, Liao JK. NF-kappaB and innate immunity in ischemic stroke. Ann N Y Acad Sci 1207: 32-40, 2010.
19. Herskowitz A, Mangano Inflammatory cascade DT. A final common pathway for perioperative injury? Anesthesiology 85: 957-960, 1996.
20. Jobs A, Schmidt K, Schmidt VJ, Lubkemeier I, van Veen TA, Kurtz A, Willecke K, de WC. Defective Cx40 maintains Cx37 expression but intact Cx40 is crucial for conducted dilations irrespective of hypertension. Hypertension 60: 1422-1429, 2012.
21. Kang EY, Ponzio M, Gupta PP, Liu F, Butensky A, Gutstein DE. Identification of binding partners for the cytoplasmic loop of connexin43: a novel interaction with beta-tubulin. Cell Commun Adhes 1-10, 2009.
22. Kansui Y, Fujii K, Nakamura K, Goto K, Oniki H, Abe I, Shibata Y, Iida M. Angiotensin II receptor blockade corrects altered expression of gap junctions in vascular endothelial cells from hypertensive rats. Am J Physiol Heart Circ Physiol 287: H216-H224, 2004.
23. Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakuldee W, Makazan J, Tanguy S, Spray DC. The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol 94: 245-264, 2007
24. Krattinger N, Capponi A, Mazzolai L, Aubert JF, Caille D, Nicod P, Waeber G, Meda P, Haefliger JA. Connexin40 regulates renin production and blood pressure. Kidney Int 72: 814-822, 2007.
25. Kurtz L, Schweda F, de Wit C, Kriz W, Witzgall R, Warth R, Sauter A, Kurtz A, Wagner C. Lack of connexin 40 causes displacement of renin-producing cells from afferent arterioles to the extraglomerular mesangium. J Am Soc Nephrol 18: 1103-1111, 2007.
26. MacKenzie A. Endothelium-derived vasoactive agents, AT1 receptors and inflammation. Pharmacol Ther 131: 187-203, 2011.
27. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27: 760-765, 1996.
28. Nagai M, Terao S, Vital SA, Rodrigues SF, Yilmaz G, Granger DN. Role of blood cell-associated angiotensin II type 1 receptors in the cerebral microvascular response to ischemic stroke during angiotensin-induced hypertension. Exp Transl Stroke Med 3: 15, 2011.
29. Paiardi S, Rodella LF, De CC, Porteri E, Boari GE, Rezzani R, Rizzardi N, Platto C, Tiberio GA, Giulini SM, Rizzoni D, Agabiti-Rosei E. Immunohistochemical evaluation of microvascular rarefaction in hypertensive humans and in spontaneously hypertensive rats. Clin Hemorheol Microcirc 42: 259-268, 2009.
30. Pries AR, Hopfner M, le NF, Dewhirst MW, Secomb TW. The shunt problem: control of functional shunting in normal and tumour vasculature. Nat Rev Cancer 10: 587-593, 2010.
31. Prior BM, Lloyd PG, Ren J, Li H, Yang HT, Laughlin MH, Terjung RL. Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats. Am J Physiol Heart Circ Physiol 287: H2434-H2447, 2004.
32. Salvemini D, Mazzon E, Dugo L, Riley DP, Serraino I, Caputi AP, Cuzzocrea S. Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br J Pharmacol 132: 815-827, 2001.
33. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, Imaizumi T. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 109: 603-611, 2002.
34. Shireman PK. The chemokine system in arteriogenesis and hind limb ischemia. J Vasc Surg 45, Suppl A: A48-A56, 2007.
35. Simon AM, McWhorter AR. Decreased intercellular dye-transfer and downregulation of non-ablated connexins in aortic endothelium deficient in connexin37 or connexin40. J Cell Sci 116: 2223-2236, 2003.
36. Sullivan CJ, Doetschman T, Hoying JB. Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. J Appl Physiol 93: 2009-2017, 2002.
37. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 35: 881-900, 2003.
38. Talhouk RS, Zeinieh MP, Mikati MA, El-Sabban ME. Gap junctional intercellular communication in hypoxia-ischemia-induced neuronal injury. Prog Neurobiol 84: 57-76, 2008.
39. Wagner C, de WC, Kurtz L, Grunberger C, Kurtz A, Schweda F. Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res 100: 556-563, 2007.
40. You D, Cochain C, Loinard C, Vilar J, Mees B, Duriez M, Levy BI, Silvestre JS. Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents. Hypertension 51: 1537-1544, 2008.
41. Zahler S, Hoffmann A, Gloe T, Pohl U. Gap-junctional coupling between neutrophils and endothelial cells: a novel modulator of transendothelial migration. J Leukoc Biol 73: 118-126, 2003.
42. Zhang J, Wang W, Sun J, Li Q, Liu J, Zhu H, Chen T, Wang H, Yu S, Sun G, Chen W, Yi D. Gap junction channel modulates pulmonary vascular permeability through calcium in acute lung injury: an experimental study. Respiration 80: 236-245, 2010.